Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arubendol
2. Asthmoprotect
3. Brethaire
4. Brethine
5. Bricanyl
6. Bricanyl Sa
7. Butaliret
8. Butalitab
9. Contimit
10. Kwd 2019
11. Kwd-2019
12. Kwd2019
13. Monovent
14. Taziken
15. Tedipulmo
16. Terbasmin
17. Terbul
18. Terbutalin Al
19. Terbutalin Ratiopharm
20. Terbutalin Stada
21. Terbutalin Von Ct
22. Terbutalin-ratiopharm
23. Terbutaline
24. Terbutaline Sulfate
25. Terbuturmant
1. Terbutaline Solution
2. Terbutaline (sulfate)
3. Mls000069693
4. Smr000058516
5. Kwd-2019
6. Sr-01000000174
7. Opera_id_498
8. Schembl41870
9. Mls001148384
10. Spectrum1500558
11. Chembl1160544
12. Regid_for_cid_657301
13. Hms500d20
14. Hms1921c15
15. Hms2092k19
16. Hms2231h10
17. Hms3259j05
18. Hms3372i16
19. Pharmakon1600-01500558
20. Ccg-39265
21. Nsc757336
22. Akos015960700
23. Nc00619
24. Ncgc00094789-01
25. Ncgc00094789-02
26. Ncgc00094789-03
27. Ncgc00094789-04
28. Ac-12158
29. Ac-33172
30. Vu0244552-7
31. Sr-01000000174-4
32. 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol,sulfuric Acid
Molecular Weight | 323.36 g/mol |
---|---|
Molecular Formula | C12H21NO7S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 323.10387318 g/mol |
Monoisotopic Mass | 323.10387318 g/mol |
Topological Polar Surface Area | 156 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 286 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Terbutaline sulfate |
Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
Active Ingredient | Terbutaline sulfate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg/ml; 5mg |
Market Status | Prescription |
Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
2 of 2 | |
---|---|
Drug Name | Terbutaline sulfate |
Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
Active Ingredient | Terbutaline sulfate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg/ml; 5mg |
Market Status | Prescription |
Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Terbutaline Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terbutaline Sulfate, including repackagers and relabelers. The FDA regulates Terbutaline Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terbutaline Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terbutaline Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terbutaline Sulfate supplier is an individual or a company that provides Terbutaline Sulfate active pharmaceutical ingredient (API) or Terbutaline Sulfate finished formulations upon request. The Terbutaline Sulfate suppliers may include Terbutaline Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Terbutaline Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Terbutaline Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Terbutaline Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Terbutaline Sulfate DMFs exist exist since differing nations have different regulations, such as Terbutaline Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Terbutaline Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Terbutaline Sulfate USDMF includes data on Terbutaline Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Terbutaline Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Terbutaline Sulfate suppliers with USDMF on PharmaCompass.
A Terbutaline Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Terbutaline Sulfate Certificate of Suitability (COS). The purpose of a Terbutaline Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Terbutaline Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Terbutaline Sulfate to their clients by showing that a Terbutaline Sulfate CEP has been issued for it. The manufacturer submits a Terbutaline Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Terbutaline Sulfate CEP holder for the record. Additionally, the data presented in the Terbutaline Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Terbutaline Sulfate DMF.
A Terbutaline Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Terbutaline Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Terbutaline Sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Terbutaline Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Terbutaline Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Terbutaline Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Terbutaline Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Terbutaline Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Terbutaline Sulfate suppliers with NDC on PharmaCompass.
Terbutaline Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Terbutaline Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Terbutaline Sulfate GMP manufacturer or Terbutaline Sulfate GMP API supplier for your needs.
A Terbutaline Sulfate CoA (Certificate of Analysis) is a formal document that attests to Terbutaline Sulfate's compliance with Terbutaline Sulfate specifications and serves as a tool for batch-level quality control.
Terbutaline Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Terbutaline Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Terbutaline Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Terbutaline Sulfate EP), Terbutaline Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Terbutaline Sulfate USP).
LOOKING FOR A SUPPLIER?